Opioid Overdose · North Dakota

Naloxone Reference

← noahpac
Opioid Overdose Recognition
👁️
Pinpoint pupils
Miosis — bilateral, non-reactive
😴
Unconsciousness
Unresponsive, cannot be aroused
🫁
Respiratory depression
RR <12, shallow, slow, or absent
Naloxone Dosing
Intranasal (IN)
Narcan® 4 mg/0.1 mL · Kloxxado® 8 mg/0.1 mL
4 mg per nostril (one spray)
Repeat every 2–3 min if no response · Alternate nostrils
First-line lay responder
Intramuscular (IM)
0.4 mg/mL vial or 2 mg/0.4 mL auto-injector (Evzio®)
0.4–2 mg IM (lateral thigh or deltoid)
Repeat every 2–3 min · Max 10 mg (if no response, reconsider diagnosis)
EMS / clinical
Intravenous (IV)
0.4 mg/mL diluted to 0.04 mg/mL
0.04–0.4 mg IV q2–3 min (titrate to respirations, not full reversal)
Infusion: 2/3 of effective bolus dose per hour if recurrence expected
Hospital setting
High-potency opioids
Fentanyl, carfentanil, nitazenes
Higher doses often needed — start with 4–8 mg IN or 2 mg IM
Multiple doses may be required. Duration of naloxone (30–90 min) shorter than most opioids — observe ≥4 hrs after last dose
Redosing critical
Renarcotization risk: Naloxone duration (30–90 min) is shorter than most opioids. Patient can re-sedate after initial response. Observe for at least 4 hours after the last effective dose. IV infusion may be needed for long-acting opioids (methadone, extended-release formulations).
North Dakota — Legal Framework
North Dakota Overdose — Key Facts
~100
ND opioid overdose deaths / year (2022–2023)
#1
Fentanyl — leading cause of overdose death in ND
77%
Of ND overdose deaths involve illicitly manufactured fentanyl
3–4×
Higher naloxone doses often needed for fentanyl vs. heroin
Resources